Phase 2 Macular Degeneration Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You are between 55 and 90 years old (inclusive).
• You have been diagnosed with advanced dry age-related macular degeneration (AMD) where the central part of your retina (the fovea) is affected by a condition called geographic atrophy.
• The affected area in your eye is within a specific size range — not too small and not too large (confirm with trial site for exact measurements).
• Your vision in the eye receiving the implant falls within a specific range — roughly between being able to read large print and being able to read moderate-sized print on an eye chart (confirm with trial site).
• Your other eye (the one not receiving the implant) has vision that is equal to or better than the eye being treated.
• You are healthy enough to undergo a specific type of eye surgery involving the implant, including being able to rest in a required position after surgery and use the prescribed eye drops or medications.
• You are medically suitable to receive general anesthesia or monitored sedation if needed during surgery.
• The eye receiving the implant has already had cataract surgery (meaning it has an artificial lens in place).
• You are willing and able to sign a written consent form agreeing to take part in the study.
• You are able to complete a specific vision sensitivity test called microperimetry at the start of the study.
• Your microperimetry test shows a certain level of remaining light sensitivity in the area around the damaged region of your retina (confirm with trial site for exact details).

Who may not be able to join:

• There are no explicit exclusion criteria listed in the provided information (confirm with trial site, as additional exclusion criteria may apply).

Important: Always verify eligibility with the trial site directly before applying.